- Home
- ZENV vs NVNO Comparison
ZENV vs NVNO Comparison
Compare ZENV & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENV
- NVNO
- Stock Information
- Founded
- ZENV 2005
- NVNO 1987
- Country
- ZENV Brazil
- NVNO United States
- Employees
- ZENV N/A
- NVNO N/A
- Industry
- ZENV Computer Software: Prepackaged Software
- NVNO Medical/Dental Instruments
- Sector
- ZENV Technology
- NVNO Health Care
- Exchange
- ZENV Nasdaq
- NVNO Nasdaq
- Market Cap
- ZENV 63.3M
- NVNO 59.4M
- IPO Year
- ZENV 2021
- NVNO N/A
- Fundamental
- Price
- ZENV $1.36
- NVNO $3.30
- Analyst Decision
- ZENV
- NVNO
- Analyst Count
- ZENV 0
- NVNO 0
- Target Price
- ZENV N/A
- NVNO N/A
- AVG Volume (30 Days)
- ZENV 80.7K
- NVNO 117.4K
- Earning Date
- ZENV 11-18-2024
- NVNO 10-31-2024
- Dividend Yield
- ZENV N/A
- NVNO N/A
- EPS Growth
- ZENV N/A
- NVNO N/A
- EPS
- ZENV N/A
- NVNO N/A
- Revenue
- ZENV $173,594,726.00
- NVNO N/A
- Revenue This Year
- ZENV $21.46
- NVNO N/A
- Revenue Next Year
- ZENV $9.29
- NVNO N/A
- P/E Ratio
- ZENV N/A
- NVNO N/A
- Revenue Growth
- ZENV 23.49
- NVNO N/A
- 52 Week Low
- ZENV $0.88
- NVNO $3.01
- 52 Week High
- ZENV $3.88
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- ZENV 54.17
- NVNO 43.55
- Support Level
- ZENV $1.12
- NVNO $3.24
- Resistance Level
- ZENV $1.55
- NVNO $3.75
- Average True Range (ATR)
- ZENV 0.12
- NVNO 0.18
- MACD
- ZENV 0.02
- NVNO 0.02
- Stochastic Oscillator
- ZENV 55.81
- NVNO 12.62
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).